Skip to content

Homoeopathic management of nasal blockage

Role of individualized homoeopathic medicines in the treatment of nasal inferior turbinate hypertrophy in adolescents and adults: An open-label, single-arm, quasi-experimental study - NIL

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/064366
Enrollment
50
Registered
2024-03-18
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J343- Hypertrophy of nasal turbinates

Interventions

Intervention1: Individualized homoeopathic medicines in centesimal potencies (CH) with concomitant care: Intervention is planned as administering indicated homoeopathic medicines in centesimal potenc
dosage and repetition depending upon the individual requirement of the cases. Patients will be advised to refrain from handling the globules or from eating, drinking, smoking or brushing teeth within

Sponsors

D.N.De Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients suffering from nasal ITH (ICD11-Code CA0E). 2. Patients aged between 12 and 65 years. 3. Patients of either sex or transgender.

Exclusion criteria

Exclusion criteria: 1.Not providing written informed assent and/or consent voluntarily. 2. Patients having nasal obstruction unrelated to inferior turbinate hypertrophy, such as symptomatic DNS, nasal polyps or tumors of nose. 3. Diagnosed cases of unstable mental or psychiatric illness or other systemic illness or life-threatening illness affecting quality of life or any organ failure. 4. Vulnerable population: Unconscious, non-ambulatory, too sick for consultation, differently abled, terminally ill or critically ill patients, and mentally incompetent people. 5. Tobacco chewing and/or smoking, alcoholism and/or any other form(s) of substance abuse and/or dependence (TAPS tool). 6. Self-reported immune-compromised state. 7. Already undergoing homoeopathic treatment for chronic disease. 8. Simultaneous participation in any other clinical trials.

Design outcomes

Primary

MeasureTime frame
NOSE scoreTimepoint: Baseline, every month, up to 3 months

Secondary

MeasureTime frame
Measure Yourself Medical Outcome Profile version2 (MYMOP-2) questionnaireTimepoint: Baseline, every month, up to 3 months;Sino Nasal Outcome Test-22 (SNOT-22)Timepoint: Baseline, every month, up to 3 months

Countries

India

Contacts

Public ContactArpita Basu

D. N. De Homoeopathic College and Hospital

drarpitasen@gmail.com9830273374

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jul 29, 2026